BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 24716976)

  • 21. The PPAR-γ agonist troglitazone antagonizes survival pathways induced by STAT-3 in recombinant interferon-β treated pancreatic cancer cells.
    Vitale G; Zappavigna S; Marra M; Dicitore A; Meschini S; Condello M; Arancia G; Castiglioni S; Maroni P; Bendinelli P; Piccoletti R; van Koetsveld PM; Cavagnini F; Budillon A; Abbruzzese A; Hofland LJ; Caraglia M
    Biotechnol Adv; 2012; 30(1):169-84. PubMed ID: 21871555
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apoptosis induced by troglitazone is both peroxisome proliferator-activated receptor-gamma- and ERK-dependent in human non-small lung cancer cells.
    Li M; Lee TW; Yim AP; Mok TS; Chen GG
    J Cell Physiol; 2006 Nov; 209(2):428-38. PubMed ID: 16883598
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peroxisome proliferator-activated receptor-gamma agonists cause growth arrest and apoptosis in human ovarian carcinoma cell lines.
    Yang YC; Tsao YP; Ho TC; Choung IP
    Int J Gynecol Cancer; 2007; 17(2):418-25. PubMed ID: 17316361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro and in vivo cytotoxicity of troglitazone in pancreatic cancer.
    Fujita M; Hasegawa A; Yamamori M; Okamura N
    J Exp Clin Cancer Res; 2017 Jul; 36(1):91. PubMed ID: 28673319
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Troglitazone, a peroxisome proliferator-activated receptor gamma ligand, induces growth inhibition and apoptosis of HepG2 human liver cancer cells.
    Zhou YM; Wen YH; Kang XY; Qian HH; Yang JM; Yin ZF
    World J Gastroenterol; 2008 Apr; 14(14):2168-73. PubMed ID: 18407589
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect and mechanism of peroxisome proliferator-activated receptor-γ on the drug resistance of the U-87 MG/CDDP human malignant glioma cell line.
    Han S; Lv X; Wang Y; Gong H; Zhang C; Tong A; Zhang B; Yao H
    Mol Med Rep; 2015 Aug; 12(2):2239-46. PubMed ID: 25891367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A peroxisome proliferator-activated receptor-gamma agonist, troglitazone, facilitates caspase-8 and -9 activities by increasing the enzymatic activity of protein-tyrosine phosphatase-1B on human glioma cells.
    Akasaki Y; Liu G; Matundan HH; Ng H; Yuan X; Zeng Z; Black KL; Yu JS
    J Biol Chem; 2006 Mar; 281(10):6165-74. PubMed ID: 16319070
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Troglitazone inhibits cell growth and induces apoptosis of B-cell acute lymphoblastic leukemia cells with t(14;18).
    Takenokuchi M; Saigo K; Nakamachi Y; Kawano S; Hashimoto M; Fujioka T; Koizumi T; Tatsumi E; Kumagai S
    Acta Haematol; 2006; 116(1):30-40. PubMed ID: 16809887
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of dectin-1-mediated dendritic cell activation by peroxisome proliferator-activated receptor-gamma ligand troglitazone.
    Kock G; Bringmann A; Held SA; Daecke S; Heine A; Brossart P
    Blood; 2011 Mar; 117(13):3569-74. PubMed ID: 21296999
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Troglitazone inhibits cell proliferation by attenuation of epidermal growth factor receptor signaling independent of peroxisome proliferator-activated receptor gamma.
    Li X; Yang X; Xu Y; Jiang X; Li X; Nan F; Tang H
    Cell Res; 2009 Jun; 19(6):720-32. PubMed ID: 19417774
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The peroxisome proliferator-activated receptor gamma ligand troglitazone induces apoptosis and p53 in rat granulosa cells.
    Lovekamp-Swan T; Chaffin CL
    Mol Cell Endocrinol; 2005 Apr; 233(1-2):15-24. PubMed ID: 15767042
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential modulation of COX-2 expression in A549 airway epithelial cells by structurally distinct PPAR(gamma) agonists: evidence for disparate functional effects which are independent of NF-(kappa)B and PPAR(gamma).
    Patel KM; Wright KL; Whittaker P; Chakravarty P; Watson ML; Ward SG
    Cell Signal; 2005 Sep; 17(9):1098-110. PubMed ID: 15993751
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peroxisome proliferator-activated receptors-gamma activator, ciglitazone, inhibits human melanocyte growth through induction of apoptosis.
    Kang HY; Lee JY; Lee JS; Choi YM
    Arch Dermatol Res; 2006 Apr; 297(10):472-6. PubMed ID: 16474974
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonist inhibits transforming growth factor-beta1 and matrix production in human dermal fibroblasts.
    Zhang GY; Cheng T; Zheng MH; Yi CG; Pan H; Li ZJ; Chen XL; Yu Q; Jiang LF; Zhou FY; Li XY; Yang JQ; Chu TG; Gao WY
    J Plast Reconstr Aesthet Surg; 2010 Jul; 63(7):1209-16. PubMed ID: 19617014
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The synergistic anticancer effect of troglitazone combined with aspirin causes cell cycle arrest and apoptosis in human lung cancer cells.
    Yan KH; Yao CJ; Chang HY; Lai GM; Cheng AL; Chuang SE
    Mol Carcinog; 2010 Mar; 49(3):235-46. PubMed ID: 19908241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synergistic interactions between heregulin and peroxisome proliferator-activated receptor-gamma (PPARgamma) agonist in breast cancer cells.
    Park BH; Lee SB; Stolz DB; Lee YJ; Lee BC
    J Biol Chem; 2011 Jun; 286(22):20087-99. PubMed ID: 21467033
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The ligands of peroxisome proliferator-activated receptor (PPAR) gamma inhibit growth of human esophageal carcinoma cells through induction of apoptosis and cell cycle arrest.
    Fujii D; Yoshida K; Tanabe K; Hihara J; Toge T
    Anticancer Res; 2004; 24(3a):1409-16. PubMed ID: 15274302
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Troglitazone-Induced Autophagic Cytotoxicity in Lung Adenocarcinoma Cell Lines.
    Tsujiya Y; Hasegawa A; Yamamori M; Okamura N
    Biol Pharm Bull; 2022; 45(3):276-283. PubMed ID: 35228393
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Troglitazone Enhances the Apoptotic Response of DLD-1 Colon Cancer Cells to Photodynamic Therapy.
    Park H; Ko SH; Lee JM; Park JH; Choi YH
    Yonsei Med J; 2016 Nov; 57(6):1494-9. PubMed ID: 27593880
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Action of thiazolidinediones on differentiation, proliferation and apoptosis of normal and transformed thyrocytes in culture.
    Fröhlich E; Machicao F; Wahl R
    Endocr Relat Cancer; 2005 Jun; 12(2):291-303. PubMed ID: 15947104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.